SMISEK JEFFERY A
Transaction: 06/07/2024
SELL
Change
-384
Price
Not reported
Filing
06/10/2024
Type
SELL
Finch Therapeutics Group, Inc.
FNCH • Biotechnology
$10.20
▲ +0.10 (+0.99%)
Current price
EarningsLatest report: Dec 31, 2024
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$16.38M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 3.39High debt level · 3.06Negative growth trendWeak profitability
Financial data as of: Dec 31, 2024, 12:00 AM UTCLast earnings update: Dec 31, 2024, 12:00 AM UTCLast profile update: Aug 13, 2026, 1:08 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$10.20
Change0.99%
Shares Out1.61M
Market Cap$16.38M
Enterprise Value$2.44M
52W Range2.00 - 16.10
Beta1.48
P/E-1.16
P/S5.76
P/B1.15
P/FCF-0.91
EV/Sales0.86
Price$10.20
Change0.99%
Shares Out1.61M
Market Cap$16.38M
Enterprise Value$2.44M
52W Range2.00 - 16.10
Beta1.48
P/E-1.16
P/S5.76
P/B1.15
P/FCF-0.91
EV/Sales0.86
EV/EBITDA-0.12
EV/FCF-0.14
Earnings Yield-86.50%
FCF Yield-110.15%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq3.06
Current Ratio3.39
Quick Ratio3.39
Revenue 5Y-100.00%
Target$159.98
Target Upside1468.43%
Target Median$159.98
Target Range159.98 - 159.98
Volume868.00
Avg Volume3.65K
EPS Surprise0.18
Investment DNA
How strong this company looks for long-term investors
35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
87/100
Why this score▼
Healthy liquidity · 3.39High debt level · 3.06Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
100/100
Bullish
Bullish
4
Hold
0
Bearish
0
Price Target
2026-08-13
Low
$159.98
Mean
$159.98
Median
$159.98
High
$159.98
Insider Transactions
Recent executive and insider activity
SMISEK JEFFERY A
Transaction: 05/20/2024
SELL
Change
-3,750
Price
Not reported
Filing
05/24/2024
Type
SELL
SMISEK JEFFERY A
Transaction: 03/28/2024
SELL
Change
-6,642
Price
$2.57
Filing
03/29/2024
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| SMISEK JEFFERY A | SELL | -384 | Not reported | 06/07/2024 | 06/10/2024 |
| SMISEK JEFFERY A | SELL | -3,750 | Not reported | 05/20/2024 | 05/24/2024 |
| SMISEK JEFFERY A | SELL | -6,642 | $2.57 | 03/28/2024 | 03/29/2024 |
| SMISEK JEFFERY A | SELL | -1,470 | $3.64 | 11/22/2023 | 11/27/2023 |
| Blischak Matthew P. | BUY | +962,899 | $0.27 | 06/09/2023 | 06/23/2023 |
| Graf Susan E | BUY | +5,010 | $0.27 | 06/09/2023 | 06/09/2023 |
| Shumway Chris | BUY | +10,000 | $0.28 | 06/08/2023 | 06/09/2023 |
| Graf Susan E | BUY | +10,000 | $0.28 | 06/08/2023 | 06/09/2023 |
| FERRANTE DOMENIC J | BUY | +10,000 | $0.28 | 06/08/2023 | 06/09/2023 |
| Haft Nicholas | BUY | +10,000 | $0.28 | 06/08/2023 | 06/09/2023 |
| SMISEK JEFFERY A | BUY | +10,000 | $0.28 | 06/08/2023 | 06/09/2023 |
| Lange Christian H. | BUY | +10,000 | $0.28 | 06/08/2023 | 06/09/2023 |
| Blischak Matthew P. | BUY | +962,899 | $0.28 | 06/08/2023 | 06/09/2023 |
| THIBAULT LANCE E | OTHER | 0 | Not reported | 05/16/2023 | 05/16/2023 |
| Blischak Matthew P. | OTHER | 0 | Not reported | 05/16/2023 | 05/16/2023 |
| Blaustein Marc | SELL | -4,619 | $0.38 | 02/21/2023 | 02/23/2023 |
| Vittiglio Joseph | SELL | -3,636 | $1.39 | 10/21/2022 | 10/25/2022 |
| Blaustein Marc | SELL | -3,636 | $1.39 | 10/21/2022 | 10/25/2022 |
| Haft Nicholas | BUY | +44,843 | Not reported | 06/13/2022 | 06/15/2022 |
| SMISEK JEFFERY A | BUY | +44,843 | $2.79 | 06/13/2022 | 06/15/2022 |